This inventor holds 1 USPTO granted patent. Top assignee: Theracos, Inc.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Debendranath Dev: Innovator in Diabetes Treatment
Introduction
Debendranath Dev is a notable inventor based in Fremont, California. He has made significant contributions to the field of diabetes treatment through his innovative research and development.
Latest Patents
Debendranath holds a patent for "Compounds to treat diabetes and associated conditions." This patent includes compounds that effectively lower blood glucose concentrations, reduce serum triglyceride concentrations, lower systolic blood pressure, and enhance glucose uptake by adipose tissue. Notably, these compounds do not affect the expression of PPAR-γ by adipose tissue, showcasing their targeted approach in diabetes management. He has 1 patent to his name.
Career Highlights
Debendranath is currently employed at Theracos, Inc., where he continues to work on innovative solutions for diabetes and related health issues. His research is pivotal in advancing treatment options for patients suffering from these conditions.
Collaborations
Throughout his career, Debendranath has collaborated with esteemed colleagues, including Frederick J. Lakner and Bishwajit Nag. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.
Conclusion
Debendranath Dev's work in the field of diabetes treatment exemplifies the impact of innovation in healthcare. His contributions are vital for improving the quality of life for individuals affected by diabetes.